Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost 0.01% vs Travoprost/Timolol in Glaucoma/OHT
NCT02097719Phase 4Completed
- Sponsor
- Allergan
- Start
- May 2014
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bimatoprost in Glaucoma and ocular hypertension (2 arms), sponsored by Allergan. Primary endpoint: Intraocular Pressure at Week 12. Started May 2014; status: completed.
02
Drugs
bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT02097719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097719.